In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point
- Alkorta, M.
- Giménez, M.J.
- Vicente, D.
- Aguilar, L.
- Pérez-Trallero, E.
ISSN: 0924-8579
Argitalpen urtea: 2005
Alea: 25
Zenbakia: 2
Orrialdeak: 163-167
Mota: Artikulua